Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NATIONAL RESEARCH CORP Director's Dealing 2021

Jan 7, 2021

33341_dirs_2021-01-07_ed69457f-fda2-4ef1-90c5-aeae8a9b6a97.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NATIONAL RESEARCH CORP (NRC)
CIK: 0000070487
Period of Report: 2021-01-05

Reporting Person: RAASCH JONA S (COO, NRC Health)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-05 Employee Stock Option (right to buy) $42.92 A 10485 Acquired 2031-01-05 Common Stock (10485) Direct

Footnotes

F1: This option becomes fully exercisable on January 5, 2026.